Gene: NQO1
Official Full Name: NAD(P)H quinone dehydrogenase 1provided by HGNC
Gene Summary: This gene is a member of the NAD(P)H dehydrogenase (quinone) family and encodes a cytoplasmic 2-electron reductase. This FAD-binding protein forms homodimers and reduces quinones to hydroquinones. This protein's enzymatic activity prevents the one electron reduction of quinones that results in the production of radical species. Mutations in this gene have been associated with tardive dyskinesia (TD), an increased risk of hematotoxicity after exposure to benzene, and susceptibility to various forms of cancer. Altered expression of this protein has been seen in many tumors and is also associated with Alzheimer's disease (AD). Alternate transcriptional splice variants, encoding different isoforms, have been characterized. [provided by RefSeq, Jul 2008]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
GP00434 | NQO1 gRNA7 KO plasmid | NQO1 | $850 | |||
GP00601 | NQO1 gRNA8 KO plasmid | NQO1 | $850 | |||
KO00815 | NQO1 Knockout cell line(22Rv1) | Human | NQO1 | 1:2~1:3 | Negative | Online Inquiry |
KO15647 | NQO1 Knockout cell line (HeLa) | Human | NQO1 | 1:3~1:6 | Negative | Online Inquiry |
KO15648 | NQO1 Knockout cell line (HCT 116) | Human | NQO1 | 1:2~1:4 | Negative | Online Inquiry |
KO15649 | NQO1 Knockout cell line (HEK293) | Human | NQO1 | 1:3~1:6 | Negative | Online Inquiry |
KO15650 | NQO1 Knockout cell line (A549) | Human | NQO1 | 1:3~1:4 | Negative | Online Inquiry |
NQO1 Gene Knockout Cell Lines are specialized cell models engineered to have a deletion or inactivation of the NAD(P)H:quinone oxidoreductase 1 (NQO1) gene. This enzyme plays a crucial role in cellular defense against oxidative stress by catalyzing the reduction of quinones and protecting cells from toxic metabolites. By eliminating the NQO1 gene, these cell lines serve as vital tools for studying the physiological and pathological roles of NQO1, including its impact on drug metabolism, redox homeostasis, and cell survival under oxidative conditions.
The primary function of NQO1 involves detoxifying harmful compounds and safeguarding cellular integrity against oxidative damage. With these knockout cell lines, researchers can directly investigate the downstream effects of NQO1 deficiency, providing insights into various diseases, including cancer and neurodegenerative disorders, where oxidative stress plays a pivotal role. Additionally, these models are invaluable for preclinical drug development, allowing for the screening of drug efficacy and safety in a controlled environment representative of NQO1-lacking conditions.
One of the significant advantages of NQO1 Gene Knockout Cell Lines is their specificity and reproducibility, delivering consistent and reliable results that can be readily compared across experiments. They offer a unique alternative to pharmacological inhibitors or siRNA approaches for studying NQO1 function, as gene knockout allows for the complete absence of the enzyme, mimicking a more physiological scenario.
Researchers and clinicians can leverage these cell lines to deepen their understanding of oxidative stress pathways, which is crucial for developing novel therapeutic strategies targeting NQO1-related pathways. The availability of these knockout cell lines enhances the capability to dissect complex biological mechanisms and identify potential biomarkers for diseases characterized by oxidative damage.
With our company's robust expertise in generating high-quality biological products tailored for research applications, we are committed to supporting the scientific community with innovative tools like the NQO1 Gene Knockout Cell Lines. Our products adhere to stringent quality standards, ensuring that you have the resources necessary for impactful research and discoveries.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.